back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-03-08 Tx date 2019-03-01 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$25,999
+6,265 vol $4.15 each |
16,932 | |
| Filed 2019-03-08 Tx date 2019-03-08 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-31,996.50
-7,710 vol $4.15 each |
17,721 | |
| Filed 2019-03-08 Tx date 2019-03-08 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$5,996
+1,445 vol $4.15 each |
1,445 | |
| Filed 2019-03-08 Tx date 2013-12-10 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,222 vol |
12,222 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,222 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
321,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
8,888 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
321,000 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
8,888 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
8,888 | |
| Filed 2018-12-27 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2018-12-27 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2018-12-27 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2018-12-27 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2018-12-27 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-774,667 vol |
55,333 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,998
+3,333 vol $4.50 each |
44,000 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-93,333 vol |
6,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-975,333 vol |
69,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-9,607,843 vol |
686,274 | |
| Filed 2018-12-21 Tx date 2014-02-17 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-46,667 vol |
3,333 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-454,085 vol |
32,435 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-19,215,686 vol |
1,372,549 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-905,333 vol |
64,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicolle d'Entremont (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-1,867 vol |
133 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Gestion Bioprisma (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,282,679 vol |
377,334 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-1,867 vol |
133 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,504,865 vol |
178,919 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell - RRSP (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-454,085 vol |
32,435 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-356,027 vol |
25,431 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
321,000 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,559,335 vol |
325,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2018-12-21 Tx date 2013-12-10 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-149,333 vol |
10,667 | |
| Filed 2018-12-21 Tx date 2013-12-10 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
8,888 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-68,627 vol |
4,902 | |
| Filed 2018-12-21 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-205,882 vol |
14,706 | |
| Filed 2018-12-21 Tx date 2014-05-31 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
8,888 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-466,667 vol |
33,333 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,222 vol |
12,222 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,961,976 vol |
140,141 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR Family Trust (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-150,980 vol |
10,784 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-19,215,686 vol |
1,372,549 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Warrants
37 - Stock split or consolidation
|
-102,941 vol |
7,353 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - TFSA (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-109,804 vol |
7,843 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Warrants
37 - Stock split or consolidation
|
-9,607,843 vol |
686,274 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-569,333 vol |
40,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - TFSA (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-54,901 vol |
3,922 | |
| Filed 2018-12-21 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-113,120 vol |
8,080 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-193,162 vol |
13,797 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR Family Trust (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-1,918,949 vol |
137,068 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-452,977 vol |
32,356 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2018-12-21 Tx date 2017-09-22 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,453,073 vol |
103,791 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Holder: The Michael and Carol Mueller Family Foundation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-23,333 vol |
1,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,392,828 vol |
170,916 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,888 vol |
8,888 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-137,254 vol |
9,804 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-56,560 vol |
4,040 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-56,560 vol |
4,040 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-233,333 vol |
16,667 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-672,000 vol |
48,000 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-371,751 vol |
26,554 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: d'Entremont Family Trust (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-9,356,676 vol |
668,334 | |
| Filed 2018-12-21 Tx date 2013-12-10 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Chretien, Sylvain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
321,000 | |
| Filed 2018-12-17 Tx date 2018-12-12 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% senior secured
36 - Conversion or exchange
|
-$100,000 vol |
$0 | |
| Filed 2018-12-17 Tx date 2018-12-12 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Convertible Debentures 12% senior secured
36 - Conversion or exchange
|
-$200,000 vol |
$0 | |
| Filed 2018-12-17 Tx date 2018-12-12 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% senior secured
36 - Conversion or exchange
|
-$100,000 vol |
$0 | |
| Filed 2018-10-26 Tx date 2018-10-26 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-30,000
-100,000 vol $0.30 each |
381,458 | |
| Filed 2018-10-26 Tx date 2018-10-26 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$30,000
+100,000 vol $0.30 each |
160,000 | |
| Filed 2018-10-26 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or director or portfolio manager of, Goodwood Inc. (Control or Direction)
|
Convertible Debentures 6% Unsecured
16 - Acquisition or disposition under a prospectus exemption
|
$
+$3,518,000 vol $0.42 each |
$3,518,000 | |
| Filed 2018-10-26 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: A fund managed by Goodwood Inc. (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+938,235 vol |
938,235 | |
| Filed 2018-10-26 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or directors of, Goodwood Inc. (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+17,777,509 vol |
17,777,509 | |
| Filed 2018-10-26 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: A fund managed by Goodwood Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$295,543
+469,117 vol $0.63 each |
469,117 | |
| Filed 2018-10-26 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or director or portfolio manager of, Goodwood Inc. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: A fund managed by Goodwood Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or directors of, Goodwood Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or director or portfolio manager of, Goodwwod Inc. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or directors of Goodwood Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or directors of Goodwood Inc. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by, or directors of, Goodwood Inc. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-23 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$18,300
+60,000 vol $0.305 each |
60,000 | |
| Filed 2018-10-24 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: A fund managed by Goodwood Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-24 Tx date 2018-10-23 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-18,300
-60,000 vol $0.305 each |
481,458 | |
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by Goodwood Inc. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$157,000 | ||
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by Goodwood Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$5,843,000 | ||
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Goodwood Inc.
3 - 10% Security Holder of Issuer
Holder: Various funds managed by Goodwood Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
110,294 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - TFSA (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
58,823 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
220,588 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,102,117 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
73,529 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR Family Trust (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,056,017 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,556,864 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicolle d'Entremont (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$50,000 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: Stephen & Kathryn Nelson - RESP (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$75,000 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
147,058 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
117,647 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - RRSP (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$100,000 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,885,002 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: d'Entremont Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,025,010 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR Family Trust (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
161,764 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
486,520 | ||
| Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell - RRSP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
486,520 | ||
| Filed 2018-10-16 Tx date 2018-10-11 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
|
$1,999,999
+5,882,352 vol $0.34 each |
5,882,352 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Warrants
36 - Conversion or exchange
|
+2,941,176 vol |
10,294,117 | |
| Filed 2018-10-16 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
36 - Conversion or exchange
|
+2,941,176 vol |
10,294,117 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$34,000
+100,000 vol $0.34 each |
250,000 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+5,882,352 vol |
20,588,235 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
36 - Conversion or exchange
|
+2,941,176 vol |
||
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Indirect Ownership)
|
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
|
-5,882,352 vol |
0 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+5,882,352 vol |
20,588,235 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
|
$-34,000
-100,000 vol $0.34 each |
0 | |
| Filed 2018-10-16 Tx date 2018-10-11 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
|
$1,999,999
+5,882,352 vol $0.34 each |
5,882,352 | |
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$31,500
+50,000 vol $0.63 each |
50,000 | |
| Filed 2018-10-16 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-16 Tx date 2017-09-22 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-16 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus
|
-5,882,352 vol |
0 | |
| Filed 2018-10-15 Tx date 2017-09-22 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-15 Tx date 2018-10-11 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
|
$34,000
+100,000 vol $0.34 each |
100,000 | |
| Filed 2018-09-21 Tx date 2018-09-19 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,500
-500 vol $35.00 each |
10,367,920 | |
| Filed 2018-09-19 Tx date 2018-09-18 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,475
-58,500 vol $0.35 each |
10,368,420 | |
| Filed 2018-09-19 Tx date 2018-09-18 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,425
-15,500 vol $0.35 each |
10,426,920 | |
| Filed 2018-09-17 Tx date 2018-09-17 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-263,025
-751,500 vol $0.35 each |
10,442,420 | |
| Filed 2018-08-31 Tx date 2018-08-30 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,400
-40,000 vol $0.46 each |
11,193,920 | |
| Filed 2018-07-10 Tx date 2018-07-06 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,750
-12,500 vol $0.46 each |
11,234,920 | |
| Filed 2018-07-10 Tx date 2018-07-09 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-460.00
-1,000 vol $0.46 each |
11,233,920 | |
| Filed 2018-07-06 Tx date 2018-07-04 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,520
-40,000 vol $0.463 each |
11,247,420 | |
| Filed 2018-01-10 Tx date 2018-01-09 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,750
+10,000 vol $0.275 each |
541,458 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+10,000 vol $0.27 each |
531,458 | |
| Filed 2017-10-18 Tx date 2017-10-16 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,160
+4,000 vol $0.29 each |
4,000 | |
| Filed 2017-10-18 Tx date 2017-10-17 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,800
+146,000 vol $0.30 each |
150,000 | |
| Filed 2017-10-18 Tx date 2017-09-22 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-26 Tx date 2017-09-22 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
100,000 | |
| Filed 2017-09-26 Tx date 2017-09-22 |
$PDP
Pediapharm Inc. |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-06 Tx date 2017-09-01 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+60,000 vol $0.25 each |
521,458 | |
| Filed 2017-09-06 Tx date 2017-09-01 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+60,000 vol $0.25 each |
206,959 | |
| Filed 2017-09-06 Tx date 2017-09-01 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-30,000
-120,000 vol $0.25 each |
2,683,784 | |
| Filed 2017-07-31 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$21,000
+70,000 vol $0.30 each |
||
| Filed 2017-07-31 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+70,000 vol $0.30 each |
533,333 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
830,000 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
1,045,000 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
970,000 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
720,000 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+80,000 vol $0.30 each |
610,000 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+70,000 vol $0.30 each |
500,000 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$21,000
+70,000 vol $0.30 each |
533,333 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Chartrand, Normand
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+70,000 vol $0.30 each |
500,000 | |
| Filed 2017-07-25 Tx date 2017-07-24 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,598.065
-8,807 vol $0.295 each |
831,304 | |
| Filed 2017-07-22 Tx date 2017-07-20 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,500
-5,000 vol $0.30 each |
840,111 | |
| Filed 2017-07-22 Tx date 2017-07-19 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,985
-10,000 vol $0.2985 each |
845,111 | |
| Filed 2017-07-19 Tx date 2017-07-17 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-10,000 vol $0.30 each |
855,111 | |
| Filed 2017-07-14 Tx date 2017-07-12 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,900
-10,000 vol $0.29 each |
865,111 | |
| Filed 2017-07-14 Tx date 2017-07-11 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,425
-5,000 vol $0.285 each |
875,111 | |
| Filed 2017-07-10 Tx date 2017-07-07 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,450
-5,000 vol $0.29 each |
880,111 | |
| Filed 2017-07-10 Tx date 2017-07-06 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,900
-10,000 vol $0.29 each |
885,111 | |
| Filed 2017-07-07 Tx date 2017-07-04 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,900
-17,500 vol $0.28 each |
895,111 | |
| Filed 2017-07-06 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
121,200 | ||
| Filed 2017-07-06 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
7,352,941 | ||
| Filed 2017-07-06 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Convertible Debentures 12% senior secured
00 - Opening Balance-Initial SEDI Report
|
$200,000 | ||
| Filed 2017-07-06 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
Leduc, Gerard Marcel
6 - Director or Senior Officer of 10% Security Holder
Holder: 9346-4626 Québec Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,705,883 | ||
| Filed 2017-07-06 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
7,352,941 | ||
| Filed 2017-07-06 Tx date 2017-06-30 |
$PDP
Pediapharm Inc. |
9346-4626 Québec Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,705,883 | ||
| Filed 2017-05-15 Tx date 2017-05-15 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,665
-121,500 vol $0.31 each |
11,287,420 | |
| Filed 2017-05-01 Tx date 2017-05-01 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,550
-28,500 vol $0.30 each |
11,408,920 | |
| Filed 2017-03-29 Tx date 2017-03-28 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,900
-10,000 vol $0.29 each |
912,611 | |
| Filed 2017-03-22 Tx date 2017-03-21 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,900
-10,000 vol $0.29 each |
922,611 | |
| Filed 2017-01-31 Tx date 2017-01-27 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,040
-14,000 vol $0.36 each |
11,437,420 | |
| Filed 2017-01-26 Tx date 2017-01-26 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,600
-35,000 vol $0.36 each |
11,451,420 | |
| Filed 2017-01-26 Tx date 2017-01-25 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,400
-90,000 vol $0.36 each |
11,486,420 | |
| Filed 2017-01-20 Tx date 2017-01-19 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,400
-60,000 vol $0.34 each |
11,716,420 | |
| Filed 2017-01-20 Tx date 2017-01-18 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,040
-188,000 vol $0.33 each |
11,776,420 | |
| Filed 2017-01-20 Tx date 2017-01-20 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,600
-140,000 vol $0.34 each |
11,576,420 | |
| Filed 2017-01-14 Tx date 2017-01-12 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,300
-10,000 vol $0.33 each |
11,964,420 | |
| Filed 2017-01-14 Tx date 2017-01-11 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-660.00
-2,000 vol $0.33 each |
11,974,420 | |
| Filed 2017-01-11 Tx date 2017-01-09 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-670.00
-2,000 vol $0.335 each |
11,976,420 | |
| Filed 2017-01-11 Tx date 2017-01-09 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,970
-9,000 vol $0.33 each |
11,978,420 | |
| Filed 2017-01-11 Tx date 2017-01-09 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-487.50
-1,500 vol $0.325 each |
11,987,420 | |
| Filed 2017-01-11 Tx date 2017-01-09 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,080
-219,000 vol $0.32 each |
11,988,920 | |
| Filed 2017-01-09 Tx date 2017-01-06 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,920
-68,500 vol $0.32 each |
12,207,920 | |
| Filed 2017-01-05 Tx date 2017-01-04 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Holder: Nemrod capital (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-47,500 vol |
89,776 | |
| Filed 2016-12-20 Tx date 2016-12-20 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,800
-10,000 vol $0.28 each |
932,611 | |
| Filed 2016-12-20 Tx date 2016-12-19 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,000
-25,000 vol $0.28 each |
942,611 | |
| Filed 2016-12-10 Tx date 2016-12-07 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,200
-20,000 vol $0.26 each |
967,611 | |
| Filed 2016-12-02 Tx date 2016-12-02 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Manon Nadeau (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-90,747 vol |
0 | |
| Filed 2016-10-17 Tx date 2016-10-14 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-27,620 vol |
987,611 | |
| Filed 2016-09-09 Tx date 2016-09-07 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,394
+47,000 vol $0.285 each |
2,563,744 | |
| Filed 2016-09-09 Tx date 2016-09-07 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$840.00
+3,000 vol $0.28 each |
2,516,744 | |
| Filed 2016-09-08 Tx date 2016-09-07 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,395
-47,000 vol $0.285 each |
1,015,231 | |
| Filed 2016-09-08 Tx date 2016-09-07 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,250
-50,000 vol $0.285 each |
||
| Filed 2016-09-01 Tx date 2016-08-30 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,250
-7,500 vol $0.30 each |
12,276,420 | |
| Filed 2016-09-01 Tx date 2016-08-29 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,760
-88,000 vol $0.27 each |
12,283,920 | |
| Filed 2016-08-27 Tx date 2016-08-24 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,500
-10,000 vol $0.25 each |
1,062,231 | |
| Filed 2016-08-26 Tx date 2016-08-24 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,620
-6,000 vol $0.27 each |
12,371,920 | |
| Filed 2016-08-26 Tx date 2016-08-23 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,000
-8,000 vol $0.25 each |
1,072,231 | |
| Filed 2016-08-26 Tx date 2016-08-22 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,500
-10,000 vol $0.25 each |
1,080,231 | |
| Filed 2016-08-18 Tx date 2016-08-18 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$15,750
+52,500 vol $0.30 each |
146,959 | |
| Filed 2016-08-18 Tx date 2016-08-18 |
$PDP
Pediapharm Inc. |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$16,249
+54,166 vol $0.30 each |
398,305 | |
| Filed 2016-08-18 Tx date 2016-08-18 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$18,499
+61,666 vol $0.30 each |
2,803,784 | |
| Filed 2016-08-18 Tx date 2016-08-18 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$8,499
+28,333 vol $0.30 each |
461,458 | |
| Filed 2016-08-16 Tx date 2016-08-11 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,125
-144,500 vol $0.25 each |
||
| Filed 2016-08-16 Tx date 2016-08-10 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,125
-144,500 vol $0.25 each |
12,383,420 | |
| Filed 2016-08-16 Tx date 2016-08-03 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,007.50
-73,500 vol $0.245 each |
12,552,420 | |
| Filed 2016-08-16 Tx date 2016-08-03 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,537.50
-67,500 vol $0.245 each |
||
| Filed 2016-08-14 Tx date 2016-08-11 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,375
-5,500 vol $0.25 each |
12,383,920 | |
| Filed 2016-08-12 Tx date 2016-08-11 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,125
-144,500 vol $0.25 each |
12,389,420 | |
| Filed 2016-08-05 Tx date 2016-08-03 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,912.50
-7,500 vol $0.255 each |
12,533,920 | |
| Filed 2016-08-05 Tx date 2016-08-03 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,250
-17,000 vol $0.25 each |
12,541,420 | |
| Filed 2016-08-05 Tx date 2016-08-03 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,537.50
-67,500 vol $0.245 each |
12,558,420 | |
| Filed 2016-08-05 Tx date 2016-08-03 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,320
-68,000 vol $0.24 each |
12,625,920 | |
| Filed 2016-07-28 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+175,000 vol $0.30 each |
463,333 | |
| Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$522.50
+1,900 vol $0.275 each |
94,459 | |
| Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,370
+31,000 vol $0.27 each |
92,559 | |
| Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+10,000 vol $0.265 each |
61,559 | |
| Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,820
+7,000 vol $0.26 each |
51,559 | |
| Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,550
+10,000 vol $0.255 each |
44,559 | |
| Filed 2016-07-28 Tx date 2016-07-27 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+4,000 vol $0.28 each |
2,742,118 | |
| Filed 2016-07-28 Tx date 2016-07-27 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,337
+8,500 vol $0.275 each |
2,738,118 | |
| Filed 2016-07-28 Tx date 2016-07-27 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,590
+6,000 vol $0.265 each |
2,729,618 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Mueller, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+175,000 vol $0.30 each |
430,000 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+175,000 vol $0.30 each |
530,000 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
620,000 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
870,000 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
945,000 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Chartrand, Normand
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+175,000 vol $0.30 each |
430,000 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
730,000 | |
| Filed 2016-07-25 Tx date 2016-07-22 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,000
-200,000 vol $0.30 each |
12,693,920 | |
| Filed 2016-07-25 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+175,000 vol $0.30 each |
430,000 | |
| Filed 2016-07-22 Tx date 2016-07-21 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,565
-98,500 vol $0.29 each |
12,893,920 | |
| Filed 2016-07-22 Tx date 2016-07-21 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-82,309.50
-301,500 vol $0.273 each |
12,992,420 | |
| Filed 2016-07-22 Tx date 2016-07-20 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,375
-125,000 vol $0.251 each |
13,293,920 | |
| Filed 2016-07-22 Tx date 2016-07-20 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,250
-125,000 vol $0.29 each |
||
| Filed 2016-07-18 Tx date 2016-07-15 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
757,500 | ||
| Filed 2016-07-18 Tx date 2016-07-15 |
$PDP
Pediapharm Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,418,920 | ||
| Filed 2016-05-24 Tx date 2016-05-20 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,750
-50,000 vol $0.175 each |
1,090,231 | |
| Filed 2016-05-24 Tx date 2016-05-20 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+50,000 vol $0.175 each |
433,125 | |
| Filed 2016-05-16 Tx date 2016-05-13 |
$PDP
Pediapharm Inc. |
Mueller, Michael Peter
4 - Director of Issuer
Holder: The Michael and Carol Mueller Family Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+25,000 vol $0.16 each |
25,000 | |
| Filed 2016-05-16 Tx date 2014-05-31 |
$PDP
Pediapharm Inc. |
Mueller, Michael Peter
4 - Director of Issuer
Holder: The Michael and Carol Mueller Family Foundation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-13 Tx date 2016-05-06 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,600
+100,000 vol $0.136 each |
175,000 | |
| Filed 2016-05-13 Tx date 2016-05-06 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+25,000 vol $0.14 each |
75,000 | |
| Filed 2016-05-09 Tx date 2016-05-06 |
$PDP
Pediapharm Inc. |
Mueller, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,775
+58,500 vol $0.15 each |
485,333 | |
| Filed 2016-05-09 Tx date 2016-05-06 |
$PDP
Pediapharm Inc. |
Mueller, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,490
+53,500 vol $0.14 each |
426,833 | |
| Filed 2015-08-26 Tx date 2015-08-25 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$11,750
+34,559 vol $0.34 each |
34,559 | |
| Filed 2015-08-26 Tx date 2014-02-17 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-26 Tx date 2015-08-25 |
$PDP
Pediapharm Inc. |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$15,499
+45,588 vol $0.34 each |
344,139 | |
| Filed 2015-08-26 Tx date 2015-08-25 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$29,999
+88,235 vol $0.34 each |
2,723,618 | |
| Filed 2015-08-10 Tx date 2015-08-10 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,912
+7,500 vol $0.255 each |
2,635,383 | |
| Filed 2015-08-10 Tx date 2015-08-10 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,625
+18,500 vol $0.25 each |
2,627,883 | |
| Filed 2015-08-10 Tx date 2015-08-10 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,430
+14,000 vol $0.245 each |
2,609,383 | |
| Filed 2015-08-10 Tx date 2015-08-10 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,360
+14,000 vol $0.24 each |
||
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,500
+75,000 vol $0.34 each |
288,333 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,500
+75,000 vol $0.34 each |
||
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Mueller, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,500
+75,000 vol $0.34 each |
255,000 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,900
+85,000 vol $0.34 each |
355,000 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,300
+145,000 vol $0.34 each |
370,000 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Hébert, Benoît
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,300
+145,000 vol $0.34 each |
620,000 | |
| Filed 2015-07-28 Tx date 2013-12-27 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Holder: pierre désormeau (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-28 Tx date 2013-12-27 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Holder: pierre désormeau (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
255,000 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,300
+195,000 vol $0.34 each |
695,000 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Chartrand, Normand
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,500
+75,000 vol $0.34 each |
255,000 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+300,000 vol $0.34 each |
480,000 | |
| Filed 2015-07-27 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Stuve, Douglas Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,500
+75,000 vol $0.34 each |
288,333 | |
| Filed 2015-07-24 Tx date 2013-12-27 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Holder: pierre désormeau (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
255,000 | ||
| Filed 2015-06-16 Tx date 2015-06-12 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-25,000 vol |
1,140,231 | |
| Filed 2015-06-16 Tx date 2015-06-11 |
$PDP
Pediapharm Inc. |
Désormeau, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-25,000 vol |
1,165,231 | |
| Filed 2014-01-24 Tx date 2014-01-22 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$124,200
+270,000 vol $0.46 each |
270,000 | |
| Filed 2014-01-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Lapalme, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2014-01-24 Tx date 2014-01-22 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,000
+500,000 vol $0.46 each |
500,000 | |
| Filed 2014-01-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Chretien, Sylvain
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2014-01-24 Tx date 2014-01-22 |
$PDP
Pediapharm Inc. |
Chartrand, Normand
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+180,000 vol $0.46 each |
180,000 | |
| Filed 2014-01-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Chartrand, Normand
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2014-01-24 Tx date 2014-01-22 |
$PDP
Pediapharm Inc. |
Botter, Angelo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+180,000 vol $0.46 each |
180,000 | |
| Filed 2014-01-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Botter, Angelo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2014-01-24 Tx date 2014-01-22 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+180,000 vol $0.46 each |
180,000 | |
| Filed 2014-01-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|